Official announcement of funding through the Canada Foundation for Innovation’s John R. Evans Leaders Fund (JELF). The Hon. Kirsty Duncan, Minister of Science and Sport, made the announcement today while visiting SFU’s Burnaby Campus. Dr. Ralph Pantophlet is one of three SFU lead researchers to receive JELF funding. The Pantophlet lab will acquire a new-generation flow cytometry system, enabling high-resolution analyses of immune responses and precise recovery of immune cells, thus stimulating new vaccine and cure strategies.
[Government of Canada announcement] [PDF]
[Simon Fraser News announcement] [PDF]

SFU has entered into a license agreement for the Trianni Mouse™, a best-in-class human monoclonal antibody discovery platform. The platform incorporates a complete human antibody repertoire and will support HIV, influenza and other vaccine research and development efforts in the Pantophlet Lab.

[article]

Our paper on a synthetic mimic of mammalian oligomannose is now out! It appears in the journal Nature Communications. Here is coverage of the paper on Vancouver’s Science in the City.

[article] [PDF]

 

Media release by SFU News of our discovery, published in Chemistry & Biology (now termed Cell Chemical Biology), of a generally harmless bacterium, Rhizobium radiobacter, that on its surface carries sugar molecules that resemble those on the surface of HIV imparted by the mammalian host cell. The discovery of these bacterial sugar molecules could help in the development of a vaccine against this still important virus.

[article] [PDF]